GW Law Faculty Publications
SSRN | Scholarly Commons
LAW REVIEW ARTICLES & CHAPTERS IN BOOKS
The More Things Change: Improvement Patents, Drug Modifications, and the FDA, 104 Iowa L. Rev. 1129 (2019).
Enhancing Patent Damages, 51 U.C. Davis L. Rev. 1427 (2018).
Divided Infringement, Economics, and the Common Law, 67 Fla. L. Rev. Forum 329 (2018), http://www.floridalawreview.com/wp-content/uploads/Karshtedt_Published.pdf.
Acceptance Instead of Denial: Pro-Applicant Positions at the PTO, 23 B.U. J. Sci. & Tech. L. 319 (2017).
Causal Responsibility and Patent Infringement, 70 Vand. L. Rev. 565 (2017).
Photocopies, Patents, and Knowledge Transfer: 'The Uneasy Case' of Justice Breyer’s Patentable Subject Matter Jurisprudence, 69 Vand. L. Rev. 1739 (2016).
The Completeness Requirement in Patent Law, 56 B.C.L. Rev. 949-1029 (2015).
The Riddle of Secret Public Use: A Response to Professor Lemley, 93 Tex. L. Rev. See Also 159-172 (2015), http://www.texaslrev.com/wp-content/uploads/2015/08/Karshtedt-93-SeeAlso.pdf.
Damages for Indirect Patent Infringement, 91 Wash. U.L. Rev. 911-978 (2014).
Did Learned Hand Get It Wrong?: The Questionable Patent Forfeiture Rule of Metallizing Engineering, 57 Vill. L. Rev. 261-337 (2012).
Contracting for a Return to the USPTO: Inter Partes Reexaminations as the Exclusive Outlet for Licensee Challenges to Patent Validity, 51 IDEA 309-356 (2011).
Limits on Hard-to-Reproduce Inventions: Process Elements and Biotechnology's Compliance with the Enablement Requirement, 3 Hastings Sci. & Tech. L. J. 109-155 (2011).
(With Alan B. Morrison, Robert L. Glicksman et al.) Who Is an Inferior Office, and Why Does It Matter?, Notice & Comment (Feb. 18, 2021), https://www.yalejreg.com/nc/who-is-an-inferior-office-and-why-does-it-matter-by-alan-b-morrison-robert-l-glicksman-dmitry-karshtedt-mark-a-lemley-joshua-d-sarnoff/.
Dmitry Karshtedt, Aaron S. Kesselheim & Michael A. Carrier, Comment Letter on Administering the Hatch-Waxman Amendments: Ensuring a Balance Between Innovation and Access, Docket FDA-2017-N-3615 (September 18, 2017), https://www.regulations.gov/document?D=FDA-2017-N-3615-0064.
Brief for Oil States Energy Services as Amicus Curiae Supporting Petitioner, Oil States Energy Services, LLC v. Greene’s Energy Group, LLC (No. 16-712) (Aug. 31, 2017), http://www.scotusblog.com/wp-content/uploads/2017/09/16-712-tsac-dmitry-karshtedt.pdf.
(With Jennifer L. McBee, Alexis T. Bell & T. Don Tilley.) Stoichiometric and Catalytic Arene Activations by Platinum Complexes Containing Bidentate Monoanionic Nitrogen-Based Ligands, Organometallics 1801-1811 (2006).
(With Alexis T. Bell and T. Don Tilley.) Reactions Involving Si-H Bond Activations by Rh and Ir Complexes Containing a Pyridylindolide Ligand, 25 Organometallics 4471-4482 (2006).
(With Alexis T. Bell & T. Don Tilley.) Platinum-Based Catalysts for the Hydroamination of Olefins with Sulfonamides and Weakly Basic Anilines, 127 J. Am. Chemical Soc'y 12640-12646 (2005).
(With Alexis T.Bell & T. Don Tilley.) Pt-Ag Catalyst System for Hydroarylations with Unactivated Arenes and Olefins, 23 Organometallics 4169-4171 (2004).
(With Alexis T.Bell & T. Don Tilley.) Syntheses and Study of Heterobimetallic Complexes Supported by a Ferrocene-Based Bisphosphine-Diamine Ligand, 22 Organometallics 2855-2862 (2003).